Akademik Veri Yönetim Sistemi
6. Uluslararası 7. Ulusal Onkoloji Hemşireliği Kongresi , Ankara, Türkiye, 20 - 22 Kasım 2024, ss.178-179, (Özet Bildiri)
Introduction and Aim: Breast cancer has the highest incidence and mortality in women. The negative side effects of chemotherapy and radiotherapy for breast cancer can disturb women and have a major impact on their lives. Anxiety, psychological stress, depression, changes in body image and other people's perceptions of cancer limit women's social interactions. In addition, work, social, economic, family and relationship problems lead to stigmatization. In this study, we aimed to test the reliability and validity of the Breast Cancer Stigma Assessment Scale (BCSAS) developed by Cenit-García et al. (2024) for breast cancer survivors in the Turkish population. Method: The research is of methodological type. The study included 352 women; Exploratory Factor Analysis (EFA) was conducted with 140 participants and Confirmatory Factor Analysis (CFA) with 212 participants. The data of the study were collected online between May and October 2024 through Personal Information Form, BCSAS and Cancer Stigma Scale (CSS). Results: After the language validity evaluated with the translation-back translation technique, the item-coverage validity index varies between 0.85-1 according to the expert opinions taken within the scope of the content validity of the scale. The content validity index of the scale is 0.88. Construct validity was examined with EFA and CFA. After EFA, eight items (1, 2, 3, 5, 11, 14, 15, 21) were removed from the scale due to factor loadings below 0.40, loading on two or more factors, not loading on any factor, and aggregating less than three items in a factor, and it was determined that the scale was explained by five factors with eigenvalues greater than 1 and 20 items (variance of explanation 62.76%). The loadings of the factors ranged between 0.445 - 0.947; 0.545 - 0.922; 0.734 - 0.877, 0.532 - 0.795; 0.536 - 0.812, respectively. According to the results obtained as a result of CFA, it was determined that the fit indices had an acceptable fit (χ2 /df=1.790 (p < 0.05), RMSEA= 0.061, SRMR=0.063, GFI: 0.883,; CFI: 0.902; IFI: 0.905; AGFI: 0.846; TLI: 0.884). The Cr α coefficients of the scale are 0.792, 0.684, 0.795, 0.710, 0.719 and 0.892 for the factors and the total scale, respectively. Item-total test correlations are between 0.431 and 0.657 in the first factor, 0.455 and 0.505 in the second factor, 0.461 and 0.569 in the third factor, 0.398 and 0.526 in the fourth factor, and 0.486 and 0.548 in the fifth factor. It was determined that there was a significant relationship at an acceptable level between BCSAS and CSS (r=0.766; p<0.001). Conclusion: The BCSAS is a valid and reliable tool to assess stigma in women with breast cancer or survivors in the Turkish population.